In 2015, more than 25,000 people inside United States died in 2015 coming from overdosing on opioids like fentanyl, oxycodone as well as hydrocodone, more than twice as many as a decade earlier, according to the Centers for Disease Control as well as Prevention in Atlanta. The drugs, either derived coming from opium or synthetic analogs of those narcotics, right now kill more Americans than homicide, as well as are approaching traffic accidents as a cause of death.
Middle-aged white men suffer disproportionately coming from opioid abuse, as well as the states with the highest overdose tolls are Ohio, Kentucky, brand new Hampshire as well as West Virginia.
The drugs were once used primarily for acute, or short-term pain, although over the last two decades, doctors have increasingly prescribed them to treat chronic pain, giving them to patients for months or years at a stretch. Drug makers promoted which change, Mr. DeWine charged in his suit, spending “millions of dollars on promotional activities as well as materials which falsely deny or trivialize the risks of opioids while overstating the benefits of using them for chronic pain.”
In addition, he said, the companies provided funding to prominent doctors, medical societies as well as patient advocacy groups to win their support for the drugs’ use. By 2012, the suit says, opioid prescriptions in Ohio equaled 68 pills a year for every resident of the state, including children.
Defendants inside case include Purdue Pharma, Teva Pharmaceutical Industries, Johnson & Johnson, Endo Pharmaceuticals, Allergan as well as others.
Purdue, the maker of OxyContin, a time-Discharge opioid, released a statement saying, “We share the attorney general’s concerns about the opioid crisis as well as we are committed to working collaboratively to find solutions,” as well as calling the company “an industry leader inside development of abuse-deterrent technology.”
Pharmaceutical Research as well as Manufacturers of America, the leading industry group, said which would certainly not comment on litigation involving specific companies.
Ohio’s lawsuit seeks to recover money the state has spent on the drugs themselves, through programs like Medicaid, as well as on addiction treatment. States took a similar approach in suing the tobacco industry inside 1990s, which eventually led to settlements worth more than $0 billion.
Continue reading the main story